4//SEC Filing
Fordham Benjamin C 4
Accession 0001209191-19-047497
CIK 0001108109other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:15 PM ET
Size
12.5 KB
Accession
0001209191-19-047497
Insider Transaction Report
Form 4
Fordham Benjamin C
EVP and General Counsel
Transactions
- Purchase
Common Stock
2019-08-27$1.85/sh+25,000$46,300→ 184,416 total
Holdings
- 26,250
Stock Options (Right to Buy)
Exercise: $4.99From: 2020-03-01Exp: 2029-02-28→ Common Stock (26,250 underlying) - 35,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (35,000 underlying) - 20,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (20,000 underlying) - 52,500
Performance Based Restricted
Exercise: $0.00→ Common Stock (52,500 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/27/2019 at prices ranging from $1.825 to $1.865, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2017 and 12/31/2019 (the "2017-2019 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2017-2019 Performance Period.
- [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 Performance Period.
- [F4]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.
Documents
Issuer
COMMUNITY HEALTH SYSTEMS INC
CIK 0001108109
Entity typeother
Related Parties
1- filerCIK 0001700942
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 4:15 PM ET
- Size
- 12.5 KB